RENBP and dengue disease: As the feasibility of sequencing directly from Ag-RDTs has recently been demonstrated for SARS-CoV-2 and considered as a potential gamechanger of SARS-CoV-2 genomic surveillance [6,7], the aim of this study was to assess the possibility of performing sequencing directly from dengue-positive Ag-RDTs tested in our routine laboratory during our 2023 summer period.